Radiolabelling of antigen and liposomes for vaccine biodistribution studies

Malou Henriksen-Lacey, Vincent Bramwell, Yvonne Perrie

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

A relatively simple and effective method to follow the movement of pharmaceutical preparations such as vaccines in biodistribution studies is to radiolabel the components. Whilst single radiolabelling is common practice, in vaccine systems containing adjuvants the ability to follow both the adjuvant and the antigen is favourable. To this end, we have devised a dual-radiolabelling method whereby the adjuvant (liposomes) is labelled with 3H and the antigen (a subunit protein) with 125I. This model is stable and reproducible; we have shown release of the radiolabels to be negligible over periods of up to 1 week in foetal calf serum at 37 ºC. In this paper we describe the techniques which enable the radiolabelling of various components, assessing stability and processing of samples which all for their application in biodistribution studies. Furthermore we provide examples derived from our studies using this model in tuberculosis vaccine biodistribution studies.
LanguageEnglish
Pages91-104
Number of pages14
JournalPharmaceutics
Volume2
Issue number2
DOIs
Publication statusPublished - 1 Mar 2010

Fingerprint

Liposomes
Vaccines
Tuberculosis Vaccines
Antigens
Protein Subunits
Serum
Pharmaceutical Preparations

Keywords

  • biodistribution
  • vaccines
  • radiolabelling
  • pharmacokinetics
  • liposomes

Cite this

Henriksen-Lacey, Malou ; Bramwell, Vincent ; Perrie, Yvonne. / Radiolabelling of antigen and liposomes for vaccine biodistribution studies. In: Pharmaceutics. 2010 ; Vol. 2, No. 2. pp. 91-104.
@article{3165c7c3c49e46e68d80e56f1a89a075,
title = "Radiolabelling of antigen and liposomes for vaccine biodistribution studies",
abstract = "A relatively simple and effective method to follow the movement of pharmaceutical preparations such as vaccines in biodistribution studies is to radiolabel the components. Whilst single radiolabelling is common practice, in vaccine systems containing adjuvants the ability to follow both the adjuvant and the antigen is favourable. To this end, we have devised a dual-radiolabelling method whereby the adjuvant (liposomes) is labelled with 3H and the antigen (a subunit protein) with 125I. This model is stable and reproducible; we have shown release of the radiolabels to be negligible over periods of up to 1 week in foetal calf serum at 37 ºC. In this paper we describe the techniques which enable the radiolabelling of various components, assessing stability and processing of samples which all for their application in biodistribution studies. Furthermore we provide examples derived from our studies using this model in tuberculosis vaccine biodistribution studies.",
keywords = "biodistribution, vaccines, radiolabelling, pharmacokinetics, liposomes",
author = "Malou Henriksen-Lacey and Vincent Bramwell and Yvonne Perrie",
year = "2010",
month = "3",
day = "1",
doi = "10.3390/pharmaceutics2020091",
language = "English",
volume = "2",
pages = "91--104",
journal = "Pharmaceutics",
issn = "1999-4923",
number = "2",

}

Radiolabelling of antigen and liposomes for vaccine biodistribution studies. / Henriksen-Lacey, Malou; Bramwell, Vincent; Perrie, Yvonne.

In: Pharmaceutics, Vol. 2, No. 2, 01.03.2010, p. 91-104.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Radiolabelling of antigen and liposomes for vaccine biodistribution studies

AU - Henriksen-Lacey, Malou

AU - Bramwell, Vincent

AU - Perrie, Yvonne

PY - 2010/3/1

Y1 - 2010/3/1

N2 - A relatively simple and effective method to follow the movement of pharmaceutical preparations such as vaccines in biodistribution studies is to radiolabel the components. Whilst single radiolabelling is common practice, in vaccine systems containing adjuvants the ability to follow both the adjuvant and the antigen is favourable. To this end, we have devised a dual-radiolabelling method whereby the adjuvant (liposomes) is labelled with 3H and the antigen (a subunit protein) with 125I. This model is stable and reproducible; we have shown release of the radiolabels to be negligible over periods of up to 1 week in foetal calf serum at 37 ºC. In this paper we describe the techniques which enable the radiolabelling of various components, assessing stability and processing of samples which all for their application in biodistribution studies. Furthermore we provide examples derived from our studies using this model in tuberculosis vaccine biodistribution studies.

AB - A relatively simple and effective method to follow the movement of pharmaceutical preparations such as vaccines in biodistribution studies is to radiolabel the components. Whilst single radiolabelling is common practice, in vaccine systems containing adjuvants the ability to follow both the adjuvant and the antigen is favourable. To this end, we have devised a dual-radiolabelling method whereby the adjuvant (liposomes) is labelled with 3H and the antigen (a subunit protein) with 125I. This model is stable and reproducible; we have shown release of the radiolabels to be negligible over periods of up to 1 week in foetal calf serum at 37 ºC. In this paper we describe the techniques which enable the radiolabelling of various components, assessing stability and processing of samples which all for their application in biodistribution studies. Furthermore we provide examples derived from our studies using this model in tuberculosis vaccine biodistribution studies.

KW - biodistribution

KW - vaccines

KW - radiolabelling

KW - pharmacokinetics

KW - liposomes

UR - http://www.mdpi.com/1999-4923/2/2/91

U2 - 10.3390/pharmaceutics2020091

DO - 10.3390/pharmaceutics2020091

M3 - Article

VL - 2

SP - 91

EP - 104

JO - Pharmaceutics

T2 - Pharmaceutics

JF - Pharmaceutics

SN - 1999-4923

IS - 2

ER -